These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 27895112

  • 21. Pharmacokinetics of vildagliptin in patients with varying degrees of renal impairment.
    He YL, Kulmatycki K, Zhang Y, Zhou W, Reynolds C, Ligueros-Saylan M, Taylor A.
    Int J Clin Pharmacol Ther; 2013 Sep; 51(9):693-703. PubMed ID: 23782585
    [Abstract] [Full Text] [Related]

  • 22. Validation of LC-MS/MS method applied to evaluation of free tissue concentrations of vildagliptin in diabetic rats by microdialysis.
    de Andrade C, de Araújo Lock G, Pigatto MC, Haas SE, Costa TD, de Araújo BV.
    Biomed Chromatogr; 2014 Dec; 28(12):1722-7. PubMed ID: 24771661
    [Abstract] [Full Text] [Related]

  • 23. Pharmacokinetics and pharmacodynamics of vildagliptin in healthy Chinese volunteers.
    Hu P, Yin Q, Deckert F, Jiang J, Liu D, Kjems L, Dole WP, He YL.
    J Clin Pharmacol; 2009 Jan; 49(1):39-49. PubMed ID: 18832295
    [Abstract] [Full Text] [Related]

  • 24. Beneficial effects of vildagliptin combined with miglitol on glucose tolerance and islet morphology in diet-controlled db/db mice.
    Ishibashi K, Hara A, Fujitani Y, Uchida T, Komiya K, Tamaki M, Abe H, Ogihara T, Kanazawa A, Kawamori R, Watada H.
    Biochem Biophys Res Commun; 2013 Nov 01; 440(4):570-5. PubMed ID: 24103756
    [Abstract] [Full Text] [Related]

  • 25. Vildagliptin in clinical practice: a review of literature.
    Banerjee M, Younis N, Soran H.
    Expert Opin Pharmacother; 2009 Nov 01; 10(16):2745-57. PubMed ID: 19874253
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Pharmacokinetics and pharmacodynamics of vildagliptin in patients with type 2 diabetes mellitus.
    He YL, Serra D, Wang Y, Campestrini J, Riviere GJ, Deacon CF, Holst JJ, Schwartz S, Nielsen JC, Ligueros-Saylan M.
    Clin Pharmacokinet; 2007 Nov 01; 46(7):577-88. PubMed ID: 17596103
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of drug efficacy of DPP-4 inhibitors based on theoretical analysis with pharmacokinetics and pharmacodynamics.
    Takayanagi R, Uchida T, Kimura K, Yamada Y.
    Biopharm Drug Dispos; 2017 May 01; 38(4):273-279. PubMed ID: 27976813
    [Abstract] [Full Text] [Related]

  • 31. Favorable effects of vildagliptin on metabolic and cognitive dysfunctions in streptozotocin-induced diabetic rats.
    El Batsh MM, El Batch MM, Shafik NM, Younos IH.
    Eur J Pharmacol; 2015 Dec 15; 769():297-305. PubMed ID: 26607467
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Adverse effects of dipeptidyl peptidases 8 and 9 inhibition in rodents revisited.
    Burkey BF, Hoffmann PK, Hassiepen U, Trappe J, Juedes M, Foley JE.
    Diabetes Obes Metab; 2008 Nov 15; 10(11):1057-61. PubMed ID: 18422675
    [Abstract] [Full Text] [Related]

  • 35. Dose proportionality and the effect of food on vildagliptin, a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers.
    Sunkara G, Sabo R, Wang Y, He YL, Campestrini J, Rosenberg M, Howard D, Dole WP.
    J Clin Pharmacol; 2007 Sep 15; 47(9):1152-8. PubMed ID: 17656620
    [Abstract] [Full Text] [Related]

  • 36. Vildagliptin selectively ameliorates GLP-1, GLUT4, SREBP-1c mRNA levels and stimulates β-cell proliferation resulting in improved glucose homeostasis in rats with streptozotocin-induced diabetes.
    Akarte AS, Srinivasan BP, Gandhi S.
    J Diabetes Complications; 2012 Sep 15; 26(4):266-74. PubMed ID: 22626875
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4).
    Thornberry NA, Gallwitz B.
    Best Pract Res Clin Endocrinol Metab; 2009 Aug 15; 23(4):479-86. PubMed ID: 19748065
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.